Clinical Trial Update: Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating retatrutide versus placebo in adults with Type 2 diabetes mellitus on diet and exercise has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Retatrutide (retatrutide)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Diabetes Type 2 | Phase 3 | Status: COMPLETED